Important note: Information in this article was accurate in 1999. The state of the art may have changed since the publication date.
TORCH testing in HIV-infected women.
Clin Obstet Gynecol. 1999 Mar;42(1):149-62; quiz 174-5. Unique Identifier : AIDSLINE MED/99172963 Helfgott A; Department of Obstetrics and Gynecology, University of; Texas-Houston Medical School, LBJ Hospital 77026, USA.
Abstract:
The issue of TORCH testing in pregnant women infected with the HIV virus remains confusing, even more so than it is in the non-HIV-infected gravida. Unfortunately, the data presented in this article make the recommendations of how to test for these various infections in pregnancy that much more difficult. Patients who are newly diagnosed as being HIV-infected and referred for prenatal care or who have not had TORCH testing probably should be tested. Thus, the prenatal patient with newly diagnosed HIV infection should be tested for T. gondii IgG antibodies. If positive for IgG antibodies, IgM antibodies should be obtained in an attempt to rule out acute T. gondii infection. Patients who test negative do not require any further testing until after the pregnancy unless they are severely immunocompromised and show signs and symptoms of toxoplasmosis. Antibodies (IgG) to CMV should be obtained in the HIV-infected gravida who is at high risk for CMV disease, i.e., patients with CD4+ T cell counts less than 100/mm3. Unfortunately, the previously described problems with antibody detection make this testing less than ideal; thus, it is not routinely recommended in the HIV-infected pregnant patient who presents for prenatal care except for those at risk of disease reactivation. As for herpes simplex virus testing, there is no value in routinely testing patients prenatally for evidence of the disease. Finally, syphilis testing in the HIV-infected gravida is of major importance. Once tested, the patient who tests negative and who remains at risk for infection should probably be retested in the third trimester. Patients who are found to have the disease and who are treated need to be tested serially to rule out re-infection or treatment failure.
Keywords: JOURNAL ARTICLE REVIEW REVIEW, TUTORIAL Acquired Immunodeficiency Syndrome/COMPLICATIONS Antibodies, Viral/ANALYSIS Cytomegalovirus Infections/*COMPLICATIONS/DIAGNOSIS Female Herpes Simplex/*COMPLICATIONS/DIAGNOSIS Human HIV Infections/*COMPLICATIONS Pregnancy *Pregnancy Complications, Infectious Serologic Tests Syphilis/*COMPLICATIONS/DIAGNOSIS Toxoplasmosis/*COMPLICATIONS/DIAGNOSIS/IMMUNOLOGY 990730
A9971129
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Important note: Information in this article was accurate in 1999. The state of the art may have changed since the publication date.
